2 penny stocks I’d buy in my Stocks and Shares ISA

I think these penny stocks could make me fatty profits over the next several years. Here’s why I’d buy them in my Stocks and Shares ISA today.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

I’m scouring UK stock indices to find the best cheap shares to buy for my Stocks and Shares ISA. Here are a couple of quality penny stocks that have caught my eye.

Healthcare hero

Today, Venture Life Group (LSE: VLG) shares go for 68p a pop. It’s a penny stock I think could make me a lot of money as its transformation strategy clicks through the gears. Venture Life manufactures non-prescription healthcare products such as Dentyl mouthwashes, Procto-eze Plus haemorrhoid creams and Myco Clear fungal nail treatments.

Acquisitions are a key part of the UK share’s growth strategy and last January it made the transformative takeover of PharmaSource BV to boost its product ranges as well as worldwide distribution.

Venture Life has also invested heavily to increase production at its Biokosmes facility in Northern Italy. Capacity here now stands at 250,000 units versus 130,000 previously.

Encouragingly, the UK healthcare share has plenty of financial clout to keep investing in the business and pursuing its M&A agenda. Indeed, a £36m share placing at the end of last year gave it the strength to acquire women’s health and diabetes product specialist BBI in June and a series of oncology support products from Helsinn Healthcare earlier this month.

I’m confident this stock’s aggressive approach to acquisitions could light a fire under long-term profits growth. But remember that an M&A-led growth strategy can be extremely risky. Meanwhile, problems like unexpected costs, underwhelming revenues, and paying over the odds for an asset can be common problems that ultimately damage shareholder returns.

A pile of British one penny coins on a white background.

A penny stock that’s too cheap to miss?

XLMedia (LSE: XLM) is another UK penny stock I’m looking closely at for my ISA today. This 58p share operates thousands of websites covering the fields of gambling, sports betting and (more recently) personal finance. And it provides digital marketing services and data to companies in these arenas. All three sectors are growing quickly and this provides plenty of opportunity for the company to exploit.

I also like this UK share because it offers excellent value for money at its current price. City analysts think annual earnings here will rocket more than 600% in 2021. This leaves the company trading on a forward price-to-earnings growth (PEG) ratio of 0.1. A reminder that any reading below 1 suggests a company could be undervalued by the market.

XLMedia is speeding up restructuring efforts in a bid to better address its vertical markets and create a more agile machine. It’s a drive that’s expected to bring down costs by reducing the global workforce by around 15% too.

Now this stock operates in markets which are subject to intense regulatory scrutiny. And this has the potential to take a bite out of earnings if the legal landscape changes. Still, in my opinion, this risk is more than reflected in XLMedia’s ultra-cheap valuation.  

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »